Abbvie

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The Company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries. Over 31,000 people in Australia currently benefit from biologics and specialty-focused AbbVie products. AbbVie is driven by responding to areas of unmet clinical need, including some of the most challenging and aggressive cancers. AbbVie globally has 190 active oncology clinical trials with 13 molecular compounds ranging from phase I, II and III representing 19 different cancer or tumour types.   

View Site